~~<i id='A057DED2AA'><strike id='A057DED2AA'><tt id='A057DED2AA'><pre id='A057DED2AA'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：fashion 2025-10-01 03:11:09 Page View：974

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Death toll from an explosion and collapse of a Paris building in June climbs to 3
Next article： Bright Health sells Medicare Advantage business to Molina

explore

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

Caitlin Bernard's story shows physicians can't shy from advocacy

JustdaysaftertheendofRoev.Wade,CaitlinBernard,anOB-GYNinIndiana,toldtheIndianapolisStaraheartbreakin

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Death toll from an explosion and collapse of a Paris building in June climbs to 3

PARIS--Awomaninher70swhoworkedatadesignschoolhasdiedastheresultofanexplosionincentralParisamonthagot